MINDSET BIOPHARMACEUTICALS (USA), INC. – Trademark Portfolio
Entity Type: 03
MINDSET BIOPHARMACEUTICALS (USA), INC. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 6 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 6 Nice Classification classes. The owner is based in NEW YORK, NY.
1450 BROADWAY, 41ST FLOOR
NEW YORK, NY 10018
Showing of trademarks Trademarks
Trademark Classifications
MINDSET BIOPHARMACEUTICALS (USA), INC.'s trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does MINDSET BIOPHARMACEUTICALS (USA), INC. have?
MINDSET BIOPHARMACEUTICALS (USA), INC. has 8 U.S. trademarks filed with the USPTO.
What trademark classes does MINDSET BIOPHARMACEUTICALS (USA), INC. file in?
MINDSET BIOPHARMACEUTICALS (USA), INC. files trademarks across 6 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 1 (Chemicals), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What is MINDSET BIOPHARMACEUTICALS (USA), INC.'s trademark registration success rate?
MINDSET BIOPHARMACEUTICALS (USA), INC. has a 0% trademark registration rate, with 0 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.